You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 7,923,021


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,923,021
Title:Local delivery method and composition
Abstract: This invention provides a rapidly degrading composition for local delivery of a medicament, such as, an antibiotic. Additionally, this invention provides a method that can be used on the battlefield to deliver antibiotics as a preliminary treatment through the use of a rapidly degrading composition.
Inventor(s): Haggard; Warren O. (Bartlett, TN), Richelsoph; Kelly C. (Belmont, NC)
Assignee: University of Memphis Research Foundation (Memphis, TN)
Application Number:12/178,312
Patent Claims:1. A local delivery composition comprising: a paste comprising calcium sulfate dihydrate, a medicament, a mixing solution and a binding agent, wherein said paste is treated to form a pellet, said pellet formulated to dissolve within 24 hours of implantation in a release environment wherein said release environment is selected from the group consisting of an open wound, tissue of a burn patient and a musculoskeletal injury.

2. A local delivery composition comprising: a paste comprising calcium sulfate dihydrate, a medicament, a mixing solution and carboxymethylcellulose, wherein said paste is treated to form a pellet and said medicament is retained in said pellet wherein said pellet substantially dissolves in a release environment within 24 hours of implantation in said release environment.

3. A method to make a local delivery composition comprising: a) mixing calcium sulfate dihydrate, a binding agent and a medicament in a mixing solution to form a paste; and b) evaporating said solution to form a pellet.

4. The method of claim 3 wherein said pellet is sterilized by gamma radiation.

5. A method to release a medicament within twenty-four hours of implantation comprising placing the composition of claim 1 into a release environment and releasing said medicament to the environment within twenty-four hours.

6. A method to release a medicament within twenty-four hours of implantation comprising placing the composition of claim 2 into a release environment and releasing said medicament to the environment within twenty-four hours.

7. The composition of claim 1 wherein said calcium sulfate dihydrate comprises 92.6%, said medicament 3.7% and said binding agent 3.7% of said local delivery composition.

8. The composition of claim 7 wherein said binding agent is carboxymethylcellulose.

9. The composition of claim 1 wherein said medicament is an antibiotic and said antibiotic comprises about 4 percent by weight of said local delivery composition.

10. The composition of claim 2 wherein said medicament is an antibiotic and said antibiotic comprises about 4 percent by weight of said local delivery composition.

11. A local delivery composition comprising: a calcium sulfate dihydrate and a binder formulated to dissolve within 24 hours of implantation in a release environment and a medicament wherein said local delivery agent is in the form of a pellet, and made by the process comprising: mixing calcium sulfate dihydrate, a binding agent and a medicament in a mixing solution to form a paste; and evaporating said solution to form a pellet.

12. The composition of claim 11 wherein the binding agent is carboxymethylcellulose.

13. The composition of claim 12 wherein said calcium sulfate dihydrate comprises 92.6%, said medicament 3.7% and said carboxymethylcellulose 3.7% of said local delivery composition.

14. The method of claims 5 wherein the release environment is an open wound.

15. The method of claims 5 wherein the release environment is the tissue of a burn patient.

16. The method of claims 5 wherein the release environment is a musculoskeletal injury.

17. The method of claim 3 wherein the binding agent is carboxymethylcellulose.

18. The method of claim 3 wherein the mixing solution is selected form the group consisting of: sterile water, saline, phosphate buffered saline, potassium chloride, potassium sulfate, EDTA, ammonium sulfate, ammonium acetate and sodium acetate.

19. The method of claim 3 wherein the binding agent is select form the group consisting of methylcellulose, hydroxypropylmethylcellulose, hydroxypropylcellulose, ethylcellulose, hydroxyethycellulose and cellulose acetate butyrate.

20. The composition of claim 2 wherein in said release environment is selected from the group consisting of an open wound, tissue of a burn patient and a musculoskeletal injury.

21. The composition of claim 1 wherein said medicament is Vancomycin and the minimum inhibitory concentration is sustained for at least twelve hours from implantation in a release environment.

22. The composition of claim 2 wherein said medicament is Vancomycin and the minimum inhibitory concentration is sustained for at least twelve hours from implantation in a release environment.

23. The composition of claim 1 wherein said medicament is selected from the group consisting of Amikacin and Gentamicin and the minimum inhibitory concentration is sustained for at least four hours from implantation in a release environment.

24. The composition of claim 2 wherein said medicament is selected from the group consisting of Amikacin and Gentamicin and the minimum inhibitory concentration is sustained for at least four hours from implantation in a release environment.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.